AI FOR SCIENCE · ON THE RECORD
GSK
On the timeline →People filter →
Research on the record
- 2026-09-21RetroChimera: organic chemists prefer an ensemble's retrosynthesis predictions to published reactionsLevel 3 · Checked against existing evidence
Graded by how far the evidence went, not how good the result is. See the methodology.
Read on AI4S.fyi
- 2026-05-21Building the Drug Discovery Engine of the Future with AI-Empowered Nodal BiologyCommentaryAnna Greka · Dædalus
Also on the timeline
- 2026-10-09GSK takes Chai Discovery's design models across its pipeline after its own lab found binders to every target it testedPartnerships
- 2026-07-30Relation expands its GSK deal to up to $110M for cell perturbation data and its MORGAN foundation modelPartnerships
- 2026-01-08GSK licenses Noetik's virtual-cell cancer models for five years: $50M upfront and in near-term milestones, then annual feesPartnerships
People
Only people the AI4S.fyi record has named: in a round, a timeline entry, commentary, an interview or a sourced role. Not the full team.
Named on AI4S.fyi
- SSarah TeichmannVice President, Translational Research Human Cell Atlas co-founder Sarah Teichmann: the single-cell reference is near a first draft, and drug development uses it first for targets and safety
Christopher AustinSVP and Head of R&D Technologies GSK takes Chai Discovery's design models across its pipeline after its own lab found binders to every target it tested
This page compiles what AI4S.fyi has recorded and links each item to its source. It is not a grade of the organization and not its complete history: a blank means the record has not caught up as often as it means nothing happened.